Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study.
Journal: International clinical psychopharmacology
Published: May 29, 2015
A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Journal: Journal of the American Academy of Child and Adolescent Psychiatry
Published: February 11, 2015
Showing 1-2 of 2
Last Updated: 09/26/2026